ZBIO

NASDAQStock

Zenas BioPharma, Inc.

$24.03-0.47 (-1.92%)

52-Week Range

$6.77
$43.17

Key Stats

Market Cap

1.0B

P/E Ratio

1.76

Dividend Yield

Beta

-1.91

Volume

307.0K

Avg Volume

574.6K

Performance

1M

-6.17%

3M

-24.82%

6M

+11.62%

YTD

-28.99%

1Y

+196.97%

3Y

+34.99%

5Y

+34.99%

Price Chart

ETF Exposure

ZBIO is held by 68 ETFs

ETFFund NameWeight
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
ZPRV.DEState Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
PreviousPage 2 of 2

About ZBIO ETF Exposure

Zenas BioPharma, Inc. (ZBIO) is held by 68 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.0B, ZBIO is a widely held institutional stock. The stock currently trades at $24.03. Investors can gain exposure to ZBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ZBIO, sorted by portfolio weight.